| Q34561820 | Allergic rhinitis and asthma in children: disease management and outcomes |
| Q34562131 | Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid-based formula induced remission in a patient with steroid-dependent, chronically active ulcerative colitis |
| Q43925125 | Comparison of five new antihistamines (H1-receptor antagonists) in patients with allergic rhinitis using nasal provocation studies and skin tests |
| Q37356447 | Complexities of diagnosis and treatment of allergic respiratory disease in the elderly |
| Q34190513 | Cytokines and cytokine receptors in allergic rhinitis: how do they relate to the Th2 hypothesis in allergy? |
| Q35054259 | Desloratadine: a nonsedating antihistamine |
| Q44609182 | Effects of fexofenadine on T-cell function in a murine model of allergen-induced airway inflammation and hyperresponsiveness |
| Q35552824 | Efficacy and safety profile of fexofenadine HCl: a unique therapeutic option in H1-receptor antagonist treatment |
| Q35895241 | Evaluating the Anti-nociceptive and Anti-inflammatory Effects of Ketotifen and Fexofenadine in Rats. |
| Q37857671 | Fexofenadine hydrochloride in the treatment of allergic disease: a review |
| Q34176032 | Fexofenadine in chronic idiopathic urticaria: a clinical and immunohistochemical evaluation |
| Q44409439 | Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis |
| Q55041721 | Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata. |
| Q33871364 | Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria |
| Q33696804 | Genetics of allergy and bronchial hyperresponsiveness |
| Q35552822 | H1-receptors: localization and role in airway physiology and in immune functions |
| Q44133019 | In vivo anti-inflammatory effects of fexofenadine in chronic idiopathic urticaria |
| Q37155868 | Influence of epinastine hydrochloride, an H1-receptor antagonist, on the function of mite allergen-pulsed murine bone marrow-derived dendritic cells in vitro and in vivo |
| Q43181140 | Interleukin-4 up-regulates histamine H1 receptors by activation of H1 receptor gene transcription |
| Q34196627 | New insights into the second generation antihistamines |
| Q34660867 | Next generation antihistamines: therapeutic rationale, accomplishments and advances |
| Q36458473 | Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis |
| Q39430561 | Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge |
| Q38129766 | Pediatric allergic rhinitis and asthma: can the march be halted? |
| Q36831075 | Predicting and establishing the clinical efficacy of a histamine h(1)-receptor antagonist : desloratadine, the model paradigm |
| Q33539610 | Pros and cons of the use of antihistamines in managing allergic rhinitis |
| Q36301605 | Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders |
| Q35041010 | Role of histamine in the pathophysiology of asthma: immunomodulatory and anti-inflammatory activities of H1-receptor antagonists |
| Q36019822 | Second-generation antihistamines: actions and efficacy in the management of allergic disorders |
| Q34355882 | Stromal interaction molecule 1 (STIM1) and Orai1 mediate histamine-evoked calcium entry and nuclear factor of activated T-cells (NFAT) signaling in human umbilical vein endothelial cells. |
| Q32019452 | Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast |
| Q33963376 | The clinical relevance of the anti-inflammatory properties of antihistamines |
| Q53262089 | The effects of inhaled house dust mite on airway barrier function and sensitivity to inhaled methacholine in mice |
| Q46473460 | The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen |
| Q73867748 | The potential of active metabolites of antihistamines in the management of allergic disease |
| Q46856712 | The various effects of four H1-antagonists on serum substance P levels in patients with atopic dermatitis |